These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34988166)

  • 1. AEBP1 as a potential immune-related prognostic biomarker in glioblastoma: a bioinformatic analyses.
    Liu M; Yu Y; Zhang Z; Chen Z; Chen B; Cheng Y; Wei Y; Li J; Shang H
    Ann Transl Med; 2021 Nov; 9(22):1657. PubMed ID: 34988166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
    Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
    Front Oncol; 2022; 12():938679. PubMed ID: 35982954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRN is a prognostic biomarker and correlated with immune infiltration in glioma: A study based on TCGA data.
    Xu SM; Xiao HY; Hu ZX; Zhong XF; Zeng YJ; Wu YX; Li D; Song T
    Front Oncol; 2023; 13():1162983. PubMed ID: 37091137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new prognostic model for glioblastoma multiforme based on coagulation-related genes.
    Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q
    Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of an immune infiltration/tumor proliferation-related Notch3 nomogram for predicting survival in patients with primary glioblastoma.
    Zheng ZQ; Zhang GG; Yuan GQ; Hao JH; Nie QQ; Zheng MC; Wang Z
    Front Genet; 2023; 14():1148126. PubMed ID: 37284062
    [No Abstract]   [Full Text] [Related]  

  • 6. Chromobox 7/8 serve as independent indicators for glioblastoma
    Zheng ZQ; Yuan GQ; Kang NL; Nie QQ; Zhang GG; Wang Z
    Front Neurol; 2022; 13():912039. PubMed ID: 36034290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinster homolog 2 reduces malignancies of glioblastoma via PTEN/PI3K/AKT pathway.
    Liang W; Liu M; Su Y; Wen Y; Wang L; Shan J; Zhao J; Xie K; Wang J
    IUBMB Life; 2024 Mar; 76(3):140-160. PubMed ID: 37728571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
    Liu J; Xu K; Ma L; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell immune regulator 1 is a prognostic marker associated with immune infiltration in glioblastoma multiforme.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    Oncol Lett; 2021 Apr; 21(4):252. PubMed ID: 33664816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across¬†multiple¬†cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Characterization of AEBP1 at Transcriptional Level in Glioma.
    Wang K; Huang R; Tong X; Wang Z; Sun S; Wu C
    Biomed Res Int; 2021; 2021():5579359. PubMed ID: 34373835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetraspanins predict the prognosis and characterize the tumor immune microenvironment of glioblastoma.
    Li YC; Wu Y; Chen G; Zhu LZ; Luo X; Nie QQ; Zhang L; Zuo CJ
    Sci Rep; 2023 Aug; 13(1):13317. PubMed ID: 37587203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression analysis in endometriosis: Immunopathology insights, transcription factors and therapeutic targets.
    Geng R; Huang X; Li L; Guo X; Wang Q; Zheng Y; Guo X
    Front Immunol; 2022; 13():1037504. PubMed ID: 36532015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and Validation of an Immune-Related Risk Score Model for Survival Prediction in Glioblastoma.
    Ren W; Jin W; Liang Z
    Front Neurol; 2022; 13():832944. PubMed ID: 35370869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of carboxypeptidase Q and its methylation in glioblastoma.
    Liu Q; Wang R; Li Z; Peng Y; Qin W; Peng XM; Liu ZG
    Transl Cancer Res; 2023 May; 12(5):1073-1087. PubMed ID: 37304538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma.
    Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L
    Front Oncol; 2022; 12():1004324. PubMed ID: 36465369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Progression Related Gene
    Sun L; Yan T; Yang B
    Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Candidate Genes Associated With Prognosis in Glioblastoma.
    Li R; Jiang Q; Tang C; Chen L; Kong D; Zou C; Lin Y; Luo J; Zou D
    Front Mol Neurosci; 2022; 15():913328. PubMed ID: 35875673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.